NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medical Letter on the CDC & FDA

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cosmetics



OTC progesterone cream results in significant drug exposure



July 24th, 2005

Over-the-counter (OTC) progesterone cream produces significant drug exposure compared to a Food and Drug Administration-approved oral progesterone product.

According to recent research from the United States, "Progesterone products are available in prescription form as well as over-the-counter (OTC) topical preparations sold for 'cosmetic' uses.

"In a randomized study design, the authors compared the drug exposure from an OTC progesterone cream to a Food and Drug Administration-approved oral preparation at the labeled daily doses recommended for each product. Twelve healthy postmenopausal women received 200 mg oral progesterone capsules once daily...


Source: Medical Letter on the CDC & FDA (2005-07-24)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login